# AARTIPHARM share price, delivery % and history — Aarti Pharmalabs Limited

> Delivery percentage for Aarti Pharmalabs Limited (AARTIPHARM) against its own history, with 910 sessions of split-adjusted NSE data from 2023 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/AARTIPHARM

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 953.75 INR (-1.96% on the day), 2026-09-30
- Delivery: 36.96% of volume taken to demat (20-day average 42.04%)
- Volume: 9.51L shares, turnover ₹90.7Cr
- Relative volume: 1.12× of its own 20-day average

## Technicals

- RSI(14): 65.42
- ATR(14): 44.87
- SMA 50: 813.49, SMA 200: 733.99
- 52-week range: 585 – 1,002.4 (-4.85% from the high)

## Performance

- 1 week 1.45%, 1 month 12.82%, 3 months 36.8%
- 6 months 56.65%, 1 year 9.42%

## Delivery percentage

- Latest: 36.96% (2026-09-30)
- 20-day average: 42.04%
- 1-year average: 47.58%
- Percentile against its own history: 10th
- Range: 9.72% – 100% across 910 sessions with a reading

Over the last 20 sessions AARTIPHARM settled 42.0% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 47.6%, so recent sessions are running 5.5 points lower than usual. The latest session ranks higher than 10% of the 910 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 8,648.6 crore
- P/E (TTM): 40.58 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 23.51 INR, split-adjusted to match the price series
- Revenue growth: 38.74% YoY, -8.04% QoQ
- Profit growth: 53.82% YoY, 24.57% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 0.49% | -2.73% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 458 | 390.7 | 71.8 | 54.6 | 6.03 | 11.93% |
| 2024-12-31 | 537.8 | 442.2 | 100.6 | 74 | 8.16 | 13.76% |
| 2025-03-31 | 563.8 | 447.5 | 114.6 | 88.3 | 9.75 | 15.67% |
| 2025-06-30 | 386.2 | 320.5 | 67.3 | 49.5 | 5.46 | 12.82% |
| 2025-09-30 | 418.3 | 379.1 | 39.3 | 27.9 | 3.08 | 6.67% |
| 2025-12-31 | 432.3 | 371.2 | 57.9 | 48 | 5.29 | 11.09% |
| 2026-03-31 | 582.6 | 514.5 | 76.2 | 61.1 | 6.74 | 10.49% |
| 2026-06-30 | 535.8 | 442.6 | 93.7 | 76.1 | 8.4 | 14.21% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 42.86%
- Public: 57.14%
- FII: 8.17%, DII: 7.22%
- Promoter shares pledged: 11.08%

## Recent filings

- 2026-09-15: dividend
- 2026-08-07: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_183990_07082026200712_iXBRL_WEB.html
- 2026-07-16: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1694024_16072026022654_WEB.xml
- 2026-05-25: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_161074_25052026220955_iXBRL_WEB.html
- 2026-04-16: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1709547_07082026120524_WEB.xml
- 2026-02-16: dividend
- 2026-02-09: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_141427_09022026203714_iXBRL_WEB.html
- 2026-01-16: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1602519_16012026051610_WEB.xml

Dated by the day the company broadcast the filing. 35 events are indexed for this instrument.

## About the instrument

- Listed: 2023-01-30 — latest session 2026-09-30 (910 sessions)
- ISIN: INE0LRU01027
- Series: EQ
- Liquidity rank: #373 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/AARTIPHARM.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.